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BACKGROUND: Diabetic kidney disease is a common and severe 
microvascular complication of diabetes mellitus (DM). There are 
limited data regarding alteration of urine parameters other than 
proteinuria among DM patients.    
METHODS: Institution based cross-sectional study was conducted 
from February to May 2017 to assess alteration of urine 
parameters among DM patients at the University of Gondar 
Hospital, Northwest Ethiopia. A Systematic random sampling 
technique was used to recruit adult (≥18 years) diabetic 
participants. Data were collected after ethical requirements had 
been fulfilled. The degree of association between variables was 
evaluated through bivariable and multivariable logistic regression 
models.   
RESULTS: The majority (69.4%) of the study participants were 
type 2 DM patients. The prevalence of altered urine chemical 
parameters was 11.3% proteinuria, 4.5% ketonuria, 13.6% 
hematuria, 53.8% glucosuria, 24.9% leukocyturia and 1.7% 
positive for nitrite. Diastolic blood pressure and poor glycemic 
control were significantly associated with proteinuria. Male 
participants were 2.4 times more likely to have leukocyturia than 
female participants. The prevalence of abnormally increased 
microscopic findings was red blood cells 3.1%, white blood cells 
12.5%, epithelial cells 27.5%, yeast cells 1.7%, bacteria 17.8%, 
casts 3.7% and crystals 29.2%. 
CONCLUSIONS: The prevalence of altered urine parameters 
among DM patients is found to be considerable. These increased 
prevalences of altered urine parameters are potential indicators 
for diabetic kidney disease. 





Diabetes mellitus (DM) represents a cluster of metabolic disorders 
characterized by increased serum glucose level which is caused by 
insulin defects in terms of secretion or action (1). The worldwide 
prevalence and incidence of DM has grown significantly (2). It was 
estimated that there were 382 million diabetic individuals in 2013, 
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and DM patients are predicted to reach up to 592 
million in 2035 worldwide.  Among these, most 
people with DM are living in developing 
countries. In Ethiopia, among adults (20–79 
years), the estimated prevalence of diabetes was 
4.4% in 2013, and it is expected to rise to 5.1% in 
2035 (3).  In the world, the number of diabetic 
adults raised from 108 million (1980) to 422 
million (2014) (4). The global annual health 
expense attributable to DM  approximately ranged 
from USD  612 to 1,099  billion (5).  
Diabetes associated hyperglycemia causes 
long-standing damage, dysfunction and collapse 
of many vital organs; mainly kidneys, eyes, 
nerves, heart and blood vessels (6).   Long-term 
complications of DM include nephropathy which 
leads to renal failure, retinopathy which 
potentially causes loss of vision, autonomic 
neuropathy which causes gastrointestinal and 
cardiovascular dysfunction and peripheral 
neuropathy which causes foot ulcers (7). The 
majority of type 1 and type 2 DM patients 
develop such complications through time  (8). 
There is also high prevalence of hypertension, 
cardiovascular and peripheral vascular diseases in 
diabetic patients. Diabetes has a psychosocial 
impact on diabetic individuals and family 
members because of its social influence and 
demands of high treatment cost (9). 
Complications of DM can be prevented or 
delayed by consistent checkup and management 
of serum glucose, hypertension or serum lipid 
levels (10).      
Diabetic kidney disease (DKD) is a familiar 
and serious complication of DM. It is the primary 
cause of renal failure as well as mortality and 
morbidity in diabetic patients. DKD is caused by 
environmental and genetic factor interactions. 
DKD has an effect on 15–25% of type 1 and 30-
40% of type 2 DM patients (11). Sustained serum 
glucose level drastically reduces DKD incidence 
and prevalence. DKD progression can be also 
slowed down effectively by blood pressure 
management (12).  
The diagnosis of DKD at initial stage allows 
immediate management which improves disease 
prognosis. It is challenging to identify biomarkers 
for the management of kidney disorder progress 
in DM patients (13). Proteinuria is the marker of 
DKD and a primary indicator of kidney disorder 
progress (14). Microalbuminuria is a key 
biomarker of kidney injury (15). It is the predictor 
of kidney disorder in DM individuals and 
associates with premature mortality and morbidity 
in diabetic,  hypertensive and healthy people (16). 
Many research findings have demonstrated that 
decreasing urine albumin level reduces the risks 
of adverse kidney problems (17,18).   
The complex nature of diabetes needs 
consistent management through multi-factorial 
risk reduction approaches (19).  A comprehensive 
management approach including serum glucose 
and blood pressure control with appropriate 
treatment integrated to reduced blood lipid level, 
low protein consumption, reduced salty diet, 
continuous physical exercise, weight loss and no 
smoking habit decreases kidney disease progress 
rate in DM patients (20,21).  Thus, this study has 
presented baseline data regarding alteration of 
urine parameters among diabetic patients, which 
will potentially support in DKD assessment and 
monitoring.    
 
METHODS AND MATERIALS 
 
Study setting and population: An institution 
based cross-sectional study was conducted from 
February to May 2017 to assess alteration of urine 
parameters among DM patients at the University 
of Gondar Hospital (UoGH), Northwest Ethiopia. 
Gondar is located 738 kms northwest of Addis 
Ababa, the capital of Ethiopia. UoGH serves more 
than 5 million residents in northwestern Ethiopia. 
Approximately, 8,000 DM patients are registered 
at Chronic Illness Clinic for medical care service.  
Adult DM patients (≥18 years) who attended 
UoGH Chronic Illness Clinic for diabetes follow-
up and volunteered to give informed written 
consent were included. Critically troubled DM 
patients who were unable to communicate, 
catheterized patients and pregnant and 
menstruating women were excluded from this 
study.  
Sampling procedure: A Systematic random 
sampling technique was used to recruit adult (≥18 
years) DM study participants. The sample size 
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was determined based on a single population 
proportion formula by considering assumptions of 
95% level of confidence, 5% margin of error and 
50% prevalence of proteinuria. The total 
calculated sample size was 384. However, the 
total source population (diabetic patients) was 
approximately 8,000 (<10,000) and a sample size 
calculation correction factor (384/8000 =0.048) 
was used. Therefore, the corrected sample size 
was 366 (384/1+0.048). Among those, 353 
(96.4% response rate) adult DM participants were 
included in the study. The remaining 3.6% of the 
population did not volunteer to participate.   
Data collection: Prior to the actual data 
collection, a three-days training and 
demonstration was given for the data collectors 
(nurse and medical laboratory professionals) 
about the study participants’ rights, the objectives 
of the study, confidentiality, the procedure of 
urine sample collection and measurements, and 
how to approach and interview participants. 
Socio-demographic, clinical, behavioral and 
measurement data of the study subjects were 
collected by nurses using a pre-tested structured 
questionnaire. In addition, the urine samples were 
analyzed by medical laboratory technologist. All 
aspects of data collection process were 
supervised by experienced professionals to ensure 
data quality. 
The study participants were communicated 
early in the morning when they came to UoGH 
Chronic Illness Clinic for their regular medical 
follow-up. Primarily, the objective of the study 
and related issues were explained to study 
participants by data collectors. Written informed 
consents were signed by volunteered study 
participants. Finally, demographic, clinical and 
measurement data were collected, and at the same 
time, participants were instructed to collect and 
transport urine specimen to urinalysis laboratory. 
Ten ml of urine specimen was collected in a 
clean, dry and leak-proof urine cap. Chemical 
parameters of urine were semi-quantitatively 
assessed by urine dipsticks immediately. Then, 
the sample was centrifuged at 3,000 rpm for 5 
minutes, and the sediment was transferred to clean 
slide and evaluated microscopically. All the data 
obtained from chemical and microscopic 
examination of urine specimen were recorded on 
registration sheet prepared by authors.   
Anthropometric measurements were done by 
nurses using calibrated equipment and 
standardized techniques. Every participant’s 
weight was recorded using weight balance. 
Stadiometer was used for height measurement. 
Thus, Body Mass Index (BMI) was calculated as 
weight/height2 (kg/m2). BMI was categorized into 
<18.5 kg/m2 (underweight), 18.5–24.9 kg/m2  
(normal), 25–29.9 kg/m2 (overweight) and ≥30 
kg/m2 (obese). Waist Circumference (WC) was 
measured midway of lower rib and iliac crest. WC 
>88 cm for females and >102 cm  for males was 
considered abnormal (22).  
Mercury sphygmomanometer instrument was 
used to measure blood pressure (BP). BP was 
taken two times after participants relaxed for at 
least 15 minutes. Five minutes interval was 
recommended between the two measurements. In 
the end, the average of the two measurements was 
used as the final result. Systolic blood pressure 
≥140 mmHg or diastolic blood pressure ≥90 
mmHg or getting histories of taking anti-
hypertensive drugs were taken into account to 
classify hypertension. The current fasting blood 
glucose (FBG) data were collected from the 
patients’ registration book to group participants 
into good glycemic control (FBG ≤130 mg/dl) 
and poor glycemic control (FBG >130 mg/dl) 
(19).  
The chemical parameters of urine (protein, 
glucose, blood, leukocyte, ketone, nitrite, 
bilirubin, urobilinogen, pH and specific gravity) 
were determined and reported semi-quantitatively 
as normal, 1+, 2+, 3+ and 4+ based on the 
manufacturer’s instruction of urine dipstick test 
(ALDE Diagnostic Co., Ltd, China). Therefore, 
the above reports were classified as normal and 
altered (1+, 2+, 3+ and 4+) for the purpose of this 
study. The microscopic examination of urine was 
also performed to evaluate abnormally increased 
number of urine sediment components (red blood 
cell (RBC), white blood cell (WBC), yeast cell, 
epithelial cell, cast, crystal, and parasite). RBCs, 
WBCs and epithelial cells found >5 cells per high 
power field were considered as abnormal and any 
yeast cells, bacteria, cast and crystal observed 
were defined as abnormal. The study followed 
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standard operation procedures (SOPs) to produce 
reliable results. 
Data analysis: The data were cleared, edited and 
entered into EPI info version 3.5.3 (CDC, USA) 
and then transferred to SPSS version 20 (IBM, 
USA) software for statistical analysis. Bivariable 
and multivariable logistic regression models were 
used to determine the degree of association 
between variables. Variables having a p-value of 
≤0.2 in the bivariable model were subjected to 
multivariable analysis to avoid confounding 
variables’ effect. In addition, crude and adjusted 
odds ratios, with their 95% confidence interval, 
were used to evaluate the associations between 





Socio-demographic and clinical characteristics: 
The study recruited 353 Diabetic patients. The 
mean age was 49.3±15.2 (range: 18-85 years). 
From all participants, 138 (39.1%) had no 
education, 112 (31.7%) were housewives, 234 
(66.3%) were married, 245 (69.4%) were type 2 
DM patients and 122 (34.6%) were hypertensive 
(Table 1).   
  
Table 1: Socio-demographic and clinical characteristics of DM patients attending at University of Gondar 
Hospital, Gondar, Northwest Ethiopia, 2017 (n= 353) 
 
Variable  Category Number  Percent  
Sex Male 168 47.6 
Female 185 52.4 
Age  ≤49 155 43.9 
>49 198 56.1 
Marital status  Single 39 11.0 
Married 234 66.3 
Divorced 39 11.0 
Widowed 41 11.6 
Occupation Employed 96 27.2 
Housewife 112 31.7 
Farmer 52 14.7 
Private  61 17.3 
Other 32 9.1 
Educational status  No education 138 39.1 
Primary  76 21.5 
Secondary  61 17.3 
Higher  78 22.1 
Type of diabetes  Type 1 108 30.6 
Type 2 245 69.4 
Family history of DM Yes  40 11.3 
No  313 88.7 
Hypertension  Present  122 34.6 
Absent  231 65.4 
Waist circumference Low risk  230 65.2 
High risk 123 34.8 
Blood glucose ≤130 111 31.4 
>130 242 68.6 
Body mass index <25 218 61.8 
25-29.9 94 26.6 
≥30 41 11.6 
Total  353 100 
Prevalence of altered urine chemical 
parameters: The 259 (73.4%) study participants  
had at least one altered chemical parameter. 
Mixed alteration was: 59.8% (155/259) single, 
           Variation of Urine Parameters…                                                                   Molla A.et.al                     
 
 
DOI:  http://dx.doi.org/10.4314/ejhs.v29i1.9 
 
881 
30.9% (80/259) double, 8.9% (23/259) triple and 
0.4% (1/259) quadruple. The prevalence of altered 
urine chemical parameters was 11.3% (95% CI: 
8.2-15) proteinuria, 4.5% (95% CI: 2.5-6.8) 
ketonuria, 13.6% (95% CI: 10.2-17.3) hematuria, 
53.8% (95% CI: 48.4-58.9) glucosuria, 24.9% 
(95% CI: 20.7-29.5) leukocyturia and 1.7% (95% 




Figure 1: Alteration of urine chemical parameters of DM patients attending at University of Gondar 
Hospital, Gondar, Northwest Ethiopia, 2017 (n= 353) 
 
Risk factors associated with altered urine 
chemical parameters: Elevated diastolic blood 
pressure and poor glycemic control were 
significantly associated with proteinuria. The odds 
of hematuria was 2.4 times higher among female 
participants compared to their male counterparts. 
On the other hand, male participants were 2.4 
times more likely to have leukocyturia than 
female participants. Furthermore, the odds of 
glucosuria was 3.4 times higher among study 
participants with poor glycemic control than good 
glycemic control (Table 2).   
Alteration of urine microscopic parameters: 
The study participants, 217 (61.5%), had at least 
one urine microscopic parameter abnormality. 
Mixed abnormality was: 60% (130/217) single, 
27.6% (60/217) double, 9.7% (21/217) triple and 
2.7% (6/217) quadruple. Observed casts were 13: 
9 casts were granular and 3 casts were cellular 
(RBC, WBC or epithelial cell) and 1 was hyaline 
cast. The frequently reported crystals were 
calcium oxalate (87/103) and uric acid 
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Table 2: Factors associated with altered urine parameters of DM patients attending at University of Gondar Hospital, Gondar, 
Northwest Ethiopia, 2017 (n= 353) 
Variable  Proteinuria    COR P-value AOR P-value 
N P 
SBP  <140 257 26 1 0.013 1 0.338 
≥140 56 14 2.471(1.214-5.032) 1.573(0.623-3.971) 
DBP <90 276 28 1 0.003 1 0.002 
≥90 37 12 3.197(1.498-6.824) 3.332(1.54-7.209) 
BG ≤130 105 6 1 0.022 1 0.019 
>130 208 34 2.861(1.164-7.029) 2.979(1.199-7.4) 
                                 Hematuria 
Sex Male  152 16 1 0.036 1 0.012 
Female 153 32 1.987(1.047-3.771) 2.355(1.209-4.586) 
TDM Type 1  88 20 1.761(0.943-3.291) 0.076 1.154(1.121-4.137) 0.021 
Type 2 217 28 1 1 
HTN Present 111 11 0.52(0.255-1.059) 0.072 0.558(0.265-1.175) 0.125 
Absent  194 37 1 1 
                                 Leukocyturia 
Sex Male  140 28 1 0.001 2.4(1.442-3.994) 0.001 
Female 125 60 2.4(1.442-3.994) 1 
Age ≤49 122 33 1 0.163 1 0.534 
>49 143 55 1.422(0.867-2.332) 1.19(0.687-2.061) 
ALC Yes  31 5 0.455(0.171-1.208) 0.114 0.609(0.22-1.682) 0.338 
No  234 83 1 1 
SBP <140 217 66 1 0.162 1 0.747 
≥140 48 22 1.507(0.848-2.678) 1.127(0.546-2.323) 
DBP <90 232 72 1 0.181 1 0.2 
≥90 33 16 1.562(0.813-3.002) 1.545(0.794-3.007) 
WC Low risk 178 52 1 0.169 1 0.277 
High risk  87 36 1.416(0.862-2.327) 0.703(0.373-1.327) 
BMI <25 173 45 1 0.013 1 0.09 
25-29.9 62 32 1.984(1.158-3.399) 1.623(0.927-2.841) 
≥30 30 11 1.41(0.656-3.029) 0.379 1.033(0.465-2.297) 0.936 
                                 Glucosuria  
Age  ≤49 57 98 1.981(1.289-3.044) 0.002 1.729(1.081-2.764) 0.022 
>49 106 92 1 1  
Sex Male  71 97 1.352(0.888-2.058) 0.16 1.388(0.879-2.191) 0.159 
Female 92 93 1 1 
TDM Type 1  40 68 1.714(1.078-2.726) 0.023 1.118(0.59-2.121) 0.732 
Type 2 123 122 1 1 
DDM <120 133 167 1.638(0.909-2.952) 0.101 1.451(0.776-2.712) 0.243 
≥120 30 23 1 1 
ALC Yes  12 24 1.819(0.879-3.764) 0.107 1.473(0.658-3.301) 0.346 
No  151 166 1 1 
HTN Present 70 52 0.501(0.321-0.781) 0.002 0.557(0.343-0.905) 0.018 
Absent  93 138 1 1 
SBP <140 123 160 1 0.041 1 0.87 
≥140 40 30 0.577(0.34-0.978) 0.948(0.497-1.807) 
BG ≤130 73 38 1 0.000 1 0.000 
>130 90 152 3.244(2.026-5.195) 3.393(2.092-5.502) 
WC Low risk 98 132 1 0.067 1 0.821 
High risk  65 58 0.662(0.427-1.029) 0.931(0.504-1.722) 
BMI <25 93 125 1 0.307 1 0.733 
25-29.9 46 48 0.776(0.478-1.261) 0.911(0.532-1.559) 
≥30 24 17 0.527(0.268-1.037) 0.064 0.717(0.338-1.52) 0.385 
ALC: Alcohol consumption, AOR: Adjusted odds ratio, BG: Blood glucose, BMI: Body mass index, COR: Crude odds ratio, DBP: Diastolic blood 
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pressure, DDM: Duration of DM (in month), DM: Diabetes mellitus, HTN: Hypertension, N: Negative, P: Positive, SBP: Systolic blood pressure, TDM: 
Type of DM, WC: Waist circumference   
 
Figure 2: Alteration of urine microscopic parameters of DM patients attending at University of Gondar 




This study demonstrated that 242 (68.6%) DM 
patients had poor glycemic control (FBG >130 
mg/dl). DM patients who are unable to control 
their blood glucose level may develop 
complications, like diabetes kidney disease, 
diabetes ketoacidosis, and infection.  Therefore, 
DM patients with proteinuria (11.3%), ketonuria 
(4.5%) and leukocyturia (24.9%) are at risk of the 
above-mentioned complications. There is 
evidence that diabetes is associated with onset and 
severity of urologic disorders which result in 
complications, such as bladder, sexual 
dysfunction and urinary tract infections (23).  
The results of this study revealed 11.3% 
(95% CI: 8.2-15) prevalence of proteinuria which 
is lower than microalbuminuria findings from the 
study conducted in India (36.3%) (24) and Saudi 
Arabia (37.4%) (25) and total albuminuria 
(macroalbuminuria plus microalbuminuria) 
prevalence in Tanzania (15.6%) (26). This 
variation may be due to ethnic variation (27), 
patient mix (11) and method of determination of 
urine protein. Studies supported that there are 
racial/ethnic differences in proteinuria due to 
DKD among patients with type 2 diabetes (28). 
Our study population comprised of both type 1 
and type 2 DM patients but previous studies used 
only type 2 DM patients. A study conducted on 
young Japanese DM patients showed a higher 
incidence of nephropathy in type 2 than type 1 
DM patients; more likely, type 2 DM is the major 
cause of DKD ([29). The urine dipstick primarily 
measures albumin, but sensitivity and specificity 
are relatively lower than quantitative methods. In 
addition, most dipstick tests are sensitive to 
albumin but may not detect low concentrations of 
Bence Jones proteins and γ-globulins (30). 
Proteinuria was significantly associated with 
elevated DBP and poor glycemic control in this 
study population. However, it was not 
significantly associated with age, sex, type of DM 
and other variables.  In Saudi Arabia, 
microalbuminuria was positively related to BMI, 
hypertension, duration of DM and fasting plasma 
glucose. Similar with our study, no statistically 
significant correlation was found between 
microalbuminuria and age (25).  In India, age, 
DBP, fasting plasma glucose and duration of DM 
were found to be associated with 
microalbuminuria (24). A study in the United 
Kingdom also identified that male gender and 
increased WC were the independent risk factors 
  
                 Ethiop J Health Sci.                           Vol. 29, No. 1                             January 2019 
 
 




of albuminuria (27).  Study population diversity 
and sample size inconsistency may affect 
associated risk factors for proteinuria.   
This study showed 13.6% hematuria and 
3.1% abnormally increased number of RBCs.   
The source of this hematuria might be DKD. 
Moreover,  hematuria can be caused by other 
kidney diseases, cystitis, pyelonephritis, urinary 
tract infection, kidney stone and cancer of the 
urinary tract, which are directly or indirectly 
related to DM (31).  Hematuria was significantly 
associated with type 1 DM and female sex. In 
addition to urinary system disease, hematuria can 
happen physiologically in females who were at 
menstruation and sexual intercourse prior to the 
data collection time.   
This study depicted 24.9% leukocyturia, 
1.7% positive for nitrite, 17.8% bacteriuria and 
12.5% abnormally increased WBCs. All of the 
above figures represent the presence of infection 
in the urinary system, which is probably 
considered as the complication of DM. A study 
conducted in the Netherlands has found that 
diabetic patients were more at risk for urinary 
tract infection (UTI) than hypertensive patients 
without diabetes (32). The prevalences of 
asymptomatic bacteriuria and incidence of UTIs 
are more frequent to happen in DM patients than 
individuals without diabetes (33).  UTIs are 
familiar or serious and can lead to undesirable 
effects in type 2 DM  patients (34). Our study 
demonstrated that leukocyturia was associated 
with male sex, and different studies found that 
UTIs commonly affect diabetic women more than 
non-diabetic women  (35). The defect in urinary 
cytokine secretion and increased bacterial 
colonization of uroepithelial cells are the potential 
mechanisms of increased prevalence of UTIs in 
such patients  (36).   
In this study, poor glycemic control, younger 
age and hypertension were associated with 
glucosuria. If the blood glucose level is above the 
renal threshold, it will be excreted through urine. 
Young DM patients may have low awareness and 
practice regarding blood glucose control, and 
there is the probability of glucosuria in those 
patients. As various studies documented, 
hypertension is a common co-morbidity with DM, 
and hypertension is usually associated with 
nephropathy (37,38).  
The prevalence of altered urine parameters of 
DM patients was found to be significant. These 
increased prevalences of altered urine parameters 
are potential indicators of diabetic kidney disease. 
Proteinuria was associated with diastolic blood 
pressure and poor glycemic control. Hematuria 
was higher among female participants compared 
to their counterparts. On the other hand, male 
participants were more likely to have leukocyturia 
than females. Urine parameters could help in the 
diagnosis of diabetic kidney disease. Moreover, 
the result of this study can be used as a baseline 
data for further longitudinal and multicenter 
studies in developing countries.   
This study was conducted after obtaining 
ethical approval from the Research and Ethics 
Review Committee of the School of Biomedical 
and Laboratory Sciences, College of Medicine 
and Health Sciences, University of Gondar. 
Informed written consent was taken from each of 
the study participant to participate in the study. 
The results of this study were based on only one 
urine sample because of budget limitation. This 
study was also a cross-sectional study, and it was 
not possible to assess the alteration of urine 
parameters repeatedly for a long period.   
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